Solid Tumor Tests

Next Generation Sequencing is available on Solid Tumors to provide a comprehensive assessment of 15 genes that are commonly mutated in solid tumors. CBS Labs NGS Assays accurately detect low-frequency variants from 20 ng of starting DNA and are optimized for formalin-fixed, paraffin-embedded (FFPE) tumor tissue. Featuring a rapid workflow this panel offers a single assay for accurate, economical, and rapid analysis of solid tumors.

Gene List: